07.21.26 -- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 3: Building A Compliant Program

Achieve highly consistent and precise AAV vector genome titer measurements with this optimized ddPCR protocol. This method ensures accurate dosing and optimal cell therapy potency.

Understanding how cells function drives progress in disease research and drug discovery. Precise control of cellular environments is essential for reliable experiments and therapeutic development.

Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.

In today's fast-paced production, precision checkweighing is crucial. Discover how smart algorithms, real-time analysis, and automation optimize performance and minimize downtime.

Upgrading outdated filling systems is essential for meeting future production demands and regulatory standards. See how one manufacturer modernized its approach to ensure compliance and efficiency.

Commercial success comes from treating tech transfer as a strategic collaboration. Flexible processes, early supply chain planning, and partnerships protect timelines and drive long‑term performance.

Advanced HVLD technology delivers non-invasive, deterministic inspection for pre-filled syringes. Find out how this method improves reliability and patient safety compared to traditional approaches.

In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

Pharmaceutical manufacturing facilities require active management and engineering expertise to balance costs, plan long-term infrastructure, and minimize production downtime.

Gain insight into the challenges in today’s changing market and solutions to help successfully develop and manufacture lifesaving products.

True Annex 1 compliance requires a facility-wide contamination-control culture. Delve into how rigorous risk awareness shapes behavior at every touchpoint across a manufacturing environment.

Personalized therapies and advanced technologies are reshaping manufacturing. Examine how intelligent automation can improve flexibility, strengthen data integrity, and accelerate production.

Move beyond brochure specifications for hazardous compounding. Read about the critical airflow, structural, and pressure requirements needed to ensure long-term facility safety.